Stock Report

Anupam Rasayan Delivers Strong Q3 FY26 Performance

Posted On : 2026-02-14 14:17:03( TIMEZONE : IST )

Anupam Rasayan India Ltd. (BSE: 543275, NSE: ANURAS, ISIN: INE930P01018), a leading custom synthesis and specialty chemicals player, announced its Q3 FY26 results from Surat on February 14, 2026.

Total revenue reached ₹5,145 million, up 33% year-on-year (YoY) from ₹3,866 million in Q3 FY25. EBITDA (including other income) rose 7% YoY to ₹1,296 million, achieving a 25.20% margin. Profit after tax (PAT) grew 12% YoY to ₹606 million from ₹542 million.

For 9M FY26, consolidated revenue was ₹17,297 million with EBITDA of ₹4,024 million, reflecting robust YoY growth.

A key highlight was the definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the US, enhancing global capabilities in advanced custom synthesis and North American market access.

Mr. Anand Desai, Managing Director, commented: "I am pleased to share that for the nine months of FY26, we delivered consolidated revenue of ₹17,297 million with EBITDA of ₹4,024 million, reflecting strong year-on-year growth. For Q3 FY26, revenue stood at ₹5,124 million with EBITDA of ₹1,296 million, demonstrating continued growth momentum. A significant strategic development during the period has been the signing of a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States. This acquisition strengthens our global footprint, enhances our capabilities in advanced custom synthesis, and deepens our access to regulated markets and innovator customers in North America. It represents an important step in our journey toward becoming a global specialty chemical platform."

Shares of Anupam Rasayan India Limited was last trading in BSE at Rs. 1337.35 as compared to the previous close of Rs. 1370.85. The total number of shares traded during the day was 13689 in over 869 trades.

The stock hit an intraday high of Rs. 1364.35 and intraday low of 1330.40. The net turnover during the day was Rs. 18410621.00.